|
36 Companies |
|
49 Products |
|
49 Products |
|
44 Mechanisms of Action |
|
1 Trial |
|
1039 News |
|
| «12...9101112131415161718192021 |
- Horizant (gabapentin enacarbil XR) / Azurity Pharma, Astellas, GSK
Enrollment change: Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects (clinicaltrials.gov) - Nov 3, 2011
P1, N=36, Completed, Sponsor: XenoPort, Inc.
N=30 --> 36
- | Horizant (gabapentin enacarbil XR) / Azurity Pharma, Astellas, GSK
Trial completion: Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects (clinicaltrials.gov) - Nov 3, 2011
P1, N=36, Completed, Sponsor: XenoPort, Inc.
N=30 --> 36 Recruiting --> Completed
- Xenical (orlistat) / Roche, GSK
Trial completion: Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases (clinicaltrials.gov) - Oct 25, 2011
P2, N=200, Completed, Sponsor: Jack Yanovski
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Behavioral Effects of Obstructive Sleep Apnea in Children (clinicaltrials.gov) - Oct 20, 2011
P=N/A, N=106, Completed, Sponsor: University of Michigan
Active, not recruiting --> Completed No longer recruiting --> Completed
- || New P3 trial: Comparative Outcomes Management With Electronic Data Technology (COMET) Study (clinicaltrials.gov) - Oct 19, 2011
P3, N=238, Active, not recruiting, Sponsor: Stanford University
- ropinirole IR / Generic mfg.
Trial termination: Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration) (clinicaltrials.gov) - Oct 18, 2011
P2, N=34, Terminated, Sponsor: GlaxoSmithKline
No longer recruiting --> Completed Completed --> Terminated; Because GSK concluded that it was impossible to recruit sufficient participants within a reasonable timeframe.
- Enrollment change: Face of Sleepiness (clinicaltrials.gov) - Oct 18, 2011
P=N/A, N=30, Active, not recruiting, Sponsor: University of Michigan
Completed --> Terminated; Because GSK concluded that it was impossible to recruit sufficient participants within a reasonable timeframe. N=20 --> 30
- Enrollment change, Adverse events: Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes (clinicaltrials.gov) - Oct 18, 2011
P=N/A, N=1685, Completed, Sponsor: University of Michigan
N=20 --> 30 N=1400 --> 1685
- Enrollment closed: Face of Sleepiness (clinicaltrials.gov) - Oct 18, 2011
P=N/A, N=30, Active, not recruiting, Sponsor: University of Michigan
N=1400 --> 1685 Recruiting --> Active, not recruiting
- Trial completion, Adverse events: Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes (clinicaltrials.gov) - Oct 18, 2011
P=N/A, N=1685, Completed, Sponsor: University of Michigan
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||||| Neupro (rotigotine transdermal) / Otsuka, UCB
New P4 trial: Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome (clinicaltrials.gov) - Oct 17, 2011
P4, N=81, Completed, Sponsor: UCB BIOSCIENCES GmbH
- New P1 trial, Adherence: SCIP-PA: Tailored Intervention to Promote Positive Airway Pressure Adherence (clinicaltrials.gov) - Oct 17, 2011
P1, N=72, Active, not recruiting, Sponsor: Milton S. Hershey Medical Center
- Enrollment open: Renal Denervation in Patients With Resistant Hypertension and Obstructive Sleep Apnea (clinicaltrials.gov) - Oct 16, 2011
P2, N=60, Recruiting, Sponsor: Institute of Cardiology, Warsaw, Poland
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||| zolpidem ER / Generic mfg.
Enrollment change: A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients (clinicaltrials.gov) - Oct 4, 2011
P4, N=132, Completed, Sponsor: Astellas Pharma Inc
Not yet recruiting --> Recruiting N=180 --> 132
- | Enrollment change: Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing (clinicaltrials.gov) - Oct 4, 2011
P4, N=20, Completed, Sponsor: University of Rochester
N=180 --> 132 N=44 --> 20
- |||| zolpidem ER / Generic mfg.
Trial completion: A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients (clinicaltrials.gov) - Oct 4, 2011
P4, N=132, Completed, Sponsor: Astellas Pharma Inc
N=44 --> 20 Recruiting --> Completed
- | zolpidem ER / Generic mfg.
Trial completion: A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia Patients (clinicaltrials.gov) - Oct 4, 2011
P4, N=42, Completed, Sponsor: Astellas Pharma Inc
Recruiting --> Completed Recruiting --> Completed
- Trial completion: Identification of Sleep-Disordered Breathing in Children (clinicaltrials.gov) - Oct 2, 2011
P=N/A, N=160, Completed, Sponsor: University of Michigan
Recruiting --> Completed Active, not recruiting --> Completed
- | Belsomra (suvorexant) / Merck (MSD)
Trial completion: Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036) (clinicaltrials.gov) - Sep 29, 2011
P1, N=26, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed Recruiting --> Completed
- acetazolamide / Generic mfg.
Trial termination: Buspirone as a Potential Treatment for Recurrent Central Apnea (clinicaltrials.gov) - Sep 25, 2011
P3, N=28, Terminated, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Recruiting --> Terminated; Patient recruitment and Funding inadequate to finish trial
- |||| zaleplon / Generic mfg.
Trial completion: Study of Sleep-maintenance Activity of 3 Doses of SKP-1041 (clinicaltrials.gov) - Sep 25, 2011
P2, N=67, Completed, Sponsor: Somnus Therapeutics, Inc.
Recruiting --> Terminated; Patient recruitment and Funding inadequate to finish trial Active, not recruiting --> Completed
- ||||||| Neupro (rotigotine transdermal) / Otsuka, UCB
Trial completion, Head-to-Head: Study of SPM 962 in Patients With Restless Legs Syndrome (RLS) (clinicaltrials.gov) - Sep 20, 2011
P3, N=240, Completed, Sponsor: Otsuka Pharmaceutical Co., Ltd.
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion, Enrollment change: Sleep Disorders of Patients With Diseases of the Nervous System (clinicaltrials.gov) - Sep 7, 2011
P=N/A, N=83, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Completed N=120 --> 83 | Recruiting --> Completed
- Trial completion: Sleep Disorders of Patients With Diseases of the Nervous System (clinicaltrials.gov) - Sep 7, 2011
P=N/A, N=83, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
N=120 --> 83 | Recruiting --> Completed Recruiting --> Completed
- Trial completion: SASS: Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea (clinicaltrials.gov) - Sep 5, 2011
P=N/A, N=149, Completed, Sponsor: Case Western Reserve University
Recruiting --> Completed Recruiting --> Completed
- |||||||||| New P3 trial: Apnex Clinical Study of the Hypoglossal Nerve Stimulation (HGNS (clinicaltrials.gov) - Sep 1, 2011
P3, N=132, Recruiting, Sponsor: Apnex Medical, Inc.
- Trial completion: Three Dimensional Morphology of Upper Respiratory Tract and Mandibular Position on Obstructive Sleep Apnea (clinicaltrials.gov) - Sep 1, 2011
P=N/A, N=20, Completed, Sponsor: National Taiwan University Hospital
Recruiting --> Completed Recruiting --> Completed
- | Humira (adalimumab) / AbbVie
Trial completion: Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea (clinicaltrials.gov) - Aug 31, 2011
P4, N=20, Completed, Sponsor: Innovaderm Research Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Study of the Usability and Efficacy of a New Pediatric CPAP Mask (clinicaltrials.gov) - Aug 23, 2011
P=N/A, N=6, Completed, Sponsor: ResMed
Active, not recruiting --> Completed N=10 --> 6
- Trial completion: Study of the Usability and Efficacy of a New Pediatric CPAP Mask (clinicaltrials.gov) - Aug 23, 2011
P=N/A, N=6, Completed, Sponsor: ResMed
N=10 --> 6 Recruiting --> Completed
- New P2 trial: Lifestyle Interventions for Seniors With Apnea (clinicaltrials.gov) - Aug 22, 2011
P2, N=20, Recruiting, Sponsor: Johns Hopkins University
- Trial completion: Validation of a New Automatic Bi-level Algorithm in the Treatment of Sleep-disordered Breathing (clinicaltrials.gov) - Aug 7, 2011
P=N/A, N=150, Completed, Sponsor: Wissenschaftliches Institut Bethanien e.V
Recruiting --> Completed Recruiting --> Completed